72 related articles for article (PubMed ID: 36366525)
1. Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma
Xu X; Wang MD; Xu JH; Fan ZQ; Diao YK; Chen Z; Jia HD; Liu FB; Zeng YY; Wang XM; Wu H; Qiu W; Li C; Pawlik TM; Lau WY; Shen F; Lv GY; Yang T
Front Immunol; 2023; 14():1322233. PubMed ID: 38268916
[TBL] [Abstract][Full Text] [Related]
2. Comparative outcomes of trans-arterial radioembolization in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease-induced HCC: a retrospective analysis.
Brunson C; Struycken L; Schaub D; Ref J; Goldberg D; Hannallah J; Woodhead G; Young S
Abdom Radiol (NY); 2024 May; ():. PubMed ID: 38709344
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma: Intratumoral EpCAM-positive cancer stem cell heterogeneity identifies high-risk tumor subtype.
Krause J; von Felden J; Casar C; Fründt TW; Galaski J; Schmidt C; Jung C; Ittrich H; Weidemann SA; Krech T; Heumann A; Li J; Fischer L; Sauter G; Lohse AW; Wege H; Schulze K
BMC Cancer; 2020 Nov; 20(1):1130. PubMed ID: 33225916
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical characteristics and survival after surgery in patients with non-B and non-C hepatocellular carcinoma and hepatitis virus-related hepatocellular carcinoma.
Nishikawa H; Arimoto A; Wakasa T; Kita R; Kimura T; Osaki Y
J Cancer; 2013; 4(6):502-13. PubMed ID: 23901350
[TBL] [Abstract][Full Text] [Related]
5. The Relation between Obesity and Survival after Surgical Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma.
Nishikawa H; Arimoto A; Wakasa T; Kita R; Kimura T; Osaki Y
Gastroenterol Res Pract; 2013; 2013():430438. PubMed ID: 23710167
[TBL] [Abstract][Full Text] [Related]
6. Potential of using qFibrosis analysis to predict recurrent and survival outcome of patients with hepatocellular carcinoma after hepatic resection.
Hsiao CY; Ren Y; Chng E; Tai D; Huang KW
Oncology; 2024 Mar; ():. PubMed ID: 38527441
[TBL] [Abstract][Full Text] [Related]
7. Actionable Solutions to Achieve Health Equity in Chronic Liver Disease.
Jones PD; Lai JC; Bajaj JS; Kanwal F
Clin Gastroenterol Hepatol; 2023 Jul; 21(8):1992-2000. PubMed ID: 37061105
[TBL] [Abstract][Full Text] [Related]
8. Disparities in Hepatocellular Carcinoma Outcomes Among Subgroups of Asians and Pacific Islanders: A SEER Database Study.
Sempokuya T; Pan CW; Pattison RJ; Choi C; Nogimura A; Wong LL
J Immigr Minor Health; 2023 Aug; 25(4):824-834. PubMed ID: 37004678
[TBL] [Abstract][Full Text] [Related]
9. Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease.
Teng PC; Huang DQ; Lin TY; Noureddin M; Yang JD
Gut Liver; 2023 Jan; 17(1):24-33. PubMed ID: 36530125
[TBL] [Abstract][Full Text] [Related]
10. Current status of disparity in liver disease.
Sempokuya T; Warner J; Azawi M; Nogimura A; Wong LL
World J Hepatol; 2022 Nov; 14(11):1940-1952. PubMed ID: 36483604
[TBL] [Abstract][Full Text] [Related]
11. Liver Transplantation for NASH-Related Hepatocellular Carcinoma Versus Non-NASH Etiologies of Hepatocellular Carcinoma.
Sadler EM; Mehta N; Bhat M; Ghanekar A; Greig PD; Grant DR; Yao F; Sapisochin G
Transplantation; 2018 Apr; 102(4):640-647. PubMed ID: 29319620
[TBL] [Abstract][Full Text] [Related]
12. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y
World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076
[TBL] [Abstract][Full Text] [Related]
13. All Roads Lead to Cathepsins: The Role of Cathepsins in Non-Alcoholic Steatohepatitis-Induced Hepatocellular Carcinoma.
van Mourik H; Li M; Baumgartner S; Theys J; Shiri-Sverdlov R
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289617
[TBL] [Abstract][Full Text] [Related]
14. Higher Risk of Tumor Recurrence in NASH-Related Hepatocellular Carcinoma Following Curative Resection.
Chien SC; Lin YJ; Lee CT; Chiu YC; Chou TC; Chiu HC; Tsai HW; Su CM; Yang TH; Chiang HC; Tsai WC; Yang KC; Cheng PN
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366525
[TBL] [Abstract][Full Text] [Related]
15. Reduced Rates of Post-Transplant Recurrent Hepatocellular Carcinoma in Non-Alcoholic Steatohepatitis: A Propensity Score Matched Analysis.
Lamm R; Altshuler PJ; Patel K; Shaheen O; Amante AP; Civan J; Maley W; Frank A; Ramirez C; Glorioso J; Shah A; Dang H; Bodzin AS
Transpl Int; 2022; 35():10175. PubMed ID: 35865863
[TBL] [Abstract][Full Text] [Related]
16. Liver Resection for Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: a Multicenter Propensity Matching Analysis with HBV-HCC.
Yang T; Hu LY; Li ZL; Liu K; Wu H; Xing H; Lau WY; Pawlik TM; Zeng YY; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Li C; Wang MD; Wu MC; Shen F
J Gastrointest Surg; 2020 Feb; 24(2):320-329. PubMed ID: 30617773
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
